Prognostic and Clinical Value of Interleukin 6 and CD45⁺CD14⁺ Inflammatory Cells with PD-L1⁺/PD-L2⁺ Expression in Patients with Different Manifestation of Ovarian Cancer

Figure 5

Percentage of CD45⁺CD14⁺ cells with expression of (a) PD-L1 and (b) PD-L2 in the TMEs of OC patients.

(a)

(b)